Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,973,375 papers from all fields of science
Search
Sign In
Create Free Account
Hypophysitis
Known as:
Hypophysitides
, Hypophysitis [Disease/Finding]
An inflammatory process in the pituitary gland.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
In Blood
Lactotrophs
Microbiological
Pituitary Gland
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma
A. Faje
,
D. Lawrence
,
+5 authors
R. Sullivan
Cancer
2018
Corpus ID: 49688690
It remains unclear whether high doses of glucocorticoids have a negative impact on the efficacy of checkpoint inhibitors. To…
Expand
Highly Cited
2016
Highly Cited
2016
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.
F. Hodi
,
J. Chesney
,
+18 authors
M. Postow
The Lancet Oncology
2016
Corpus ID: 3648959
Review
2016
Review
2016
Management of toxicities of immune checkpoint inhibitors.
L. Spain
,
S. Diem
,
J. Larkin
Cancer Treatment Reviews
2016
Corpus ID: 207050565
Highly Cited
2014
Highly Cited
2014
Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody
Shintaro Iwama
,
A. de Remigis
,
M. Callahan
,
S. Slovin
,
J. Wolchok
,
P. Caturegli
Science Translational Medicine
2014
Corpus ID: 22158613
CTLA-4 blocking antibody induces secondary hypophysitis by binding to CTLA-4 antigen and initiating a type II hypersensitivity…
Expand
Review
2014
Review
2014
Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma.
A. Faje
,
R. Sullivan
,
+4 authors
L. Nachtigall
Journal of Clinical Endocrinology and Metabolism
2014
Corpus ID: 207090606
CONTEXT Ipilimumab (Ipi) is approved by the Food and Drug Administration for the treatment of unresectable or metastatic melanoma…
Expand
Review
2012
Review
2012
Management of immune-related adverse events and kinetics of response with ipilimumab.
J. Weber
,
K. Kähler
,
A. Hauschild
Journal of Clinical Oncology
2012
Corpus ID: 24534224
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab…
Expand
Highly Cited
2012
Highly Cited
2012
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate…
A. V. D. van den Eertwegh
,
J. Versluis
,
+15 authors
W. Gerritsen
The Lancet Oncology
2012
Corpus ID: 30278366
Highly Cited
2007
Highly Cited
2007
Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis
J. Yang
,
M. Hughes
,
+10 authors
S. Rosenberg
Journal of immunotherapy
2007
Corpus ID: 13765281
The inhibitory receptor CTLA4 has a key role in peripheral tolerance of T cells for both normal and tumor-associated antigens…
Expand
Highly Cited
2007
Highly Cited
2007
Autoimmune hypophysitis
田攀文
,
陈德才
,
卢春燕
2007
Corpus ID: 221155903
自身免疫性垂体炎是一种罕见的内分泌疾病,多发生于妊娠或产后.其发病机制不明,临床表现多变,主要包括垂体压迫、腺垂体功能减退症、尿崩症和高催乳素血症等相关症状.治疗目的主要是减小垂体肿块的大小和(或)替代有缺陷的内分泌功能.多数患者需要长期使用激素替代治疗。
Highly Cited
2003
Highly Cited
2003
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
G. Phan
,
J. Yang
,
+14 authors
S. Rosenberg
Proceedings of the National Academy of Sciences…
2003
Corpus ID: 24741410
Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) is a critical immunoregulatory molecule (expressed on activated T cells and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE